Cefoperazone-Induced Coagulopathy

A number of recent articles have reviewed the problem of hypoprothrombinemia and bleeding associated with antibiotic therapy. We report three cases in which bleeding is believed to be related to a prolonged prothrombin time secondary to cefoperazone therapy. Reports of coagulopathies such as these are increasing in number and call attention to the need to monitor the prothrombin time during cefoperazone therapy.

[1]  J. Osborne.  Hypoprothrombinemia and bleeding due to cefoperazone. , 1985, Annals of internal medicine.

[2]  E. Ritz,et al.  Hvpoprothrombinemia caused by cephalosporins , 1985 .

[3]  S. Meisel.  Severe Bleeding Diathesis Associated with Moxalactam Administration , 1984, Drug intelligence & clinical pharmacy.

[4]  J. Flaherty,et al.  Third-generation cephalosporins: a critical evaluation. , 1984, Clinical pharmacy.

[5]  P. Cristiano.  Hypoprothrombinemia Associated with Cefoperazone Treatment , 1984, Drug Intelligence & Clinical Pharmacy.

[6]  S. Meisel.  Hypoprothrombinemia due to cefoperazone. , 1984, Drug intelligence & clinical pharmacy.

[7]  Scott Wietecha.  Prolonged bleeding times and bleeding diathesis associated with moxalactam administration , 1983 .

[8]  Jerome J. Schentag,et al.  A Randomized Clinical Trial of Moxalactam Alone versus Tobramycin plus Clindamycin in Abdominal Sepsis , 1983, Annals of surgery.

[9]  S. Jones,et al.  Moxalactam and hemorrhage. , 1983, Annals of internal medicine.

[10]  R. Quintiliani.  Bleeding disorders associated with newer cephalosporins. , 1983, Clinical pharmacy.

[11]  S. Jenkinson.  Adverse effects of new cephalosporins. , 1983, Annals of internal medicine.

[12]  R. Glew,et al.  HYPOPROTHROMBINAEMIA AND BLEEDING ASSOCIATED WITH CEPHAMANDOLE , 1983, The Lancet.

[13]  S. Tessler,et al.  Effects of moxalactam on blood coagulation and platelet function. , 1982, Reviews of infectious diseases.

[14]  T. Russell,et al.  Coagulopathy associated with the use of moxalactam. , 1982, JAMA.

[15]  J. D'Elia,et al.  Bleeding in patients with infections. Are antibiotics helping or hurting? , 1982, Archives of internal medicine.

[16]  R. Marier,et al.  Moxalactam in the therapy of serious infections , 1982, Antimicrobial Agents and Chemotherapy.

[17]  R. Holt,et al.  Hypoprothrombinemia Associated with Moxalactam Treatment of a Septic Sternoclavicular Arthritis Due to Citrobacter Diversus , 1981, Drug intelligence & clinical pharmacy.

[18]  R. Bailey,et al.  Vitamin K deficiency developing in patients with renal failure treated with cephalosporin antibiotics. , 1980, The New Zealand medical journal.

[19]  C. W. Greenlaw,et al.  Hypoprothrombinemia Associated with Cefamandole , 1980 .

[20]  C. Hooper,et al.  GASTROINTESTINAL BLEEDING DUE TO VITAMIN K DEFICIENCY IN PATIENTS ON PARENTERAL CEFAMANDOLE , 1980, The Lancet.

[21]  Soothill Jf.  Letter: Immunoglobulin standards. , 1975 .

[22]  E. Ritz,et al.  Hypoprothrombinemia caused by cephalosporins. , 1985, The Journal of antimicrobial chemotherapy.

[23]  B. Jensen.  Moxalactam-induced coagulopathy. , 1983, Clinical pharmacy.